Palmetto establishes formal coverage policy for all Medicare patients

[News]

Genomic Health, Inc. today announced that Palmetto GBA, the designated national contractor for its Oncotype DX colon cancer test, has established a formal coverage policy for all Medicare patients.

More... (http://www.news-medical.net/news/20111001/Palmetto-establishes-formal-coverage-policy-for-all-Medicare-patients.aspx)